Lv5
1280 积分 2024-07-09 加入
Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study)
3个月前
已完结
Efficacy of recombinant human thrombopoietin in patients with acute-on-chronic liver failure and thrombocytopenia: A prospective, open-label study
3个月前
已关闭
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
4个月前
已完结
Epidemiology of liver diseases: global disease burden and forecasted research trends
4个月前
已完结
皖公网安备34019202002308
